Examining Potential Therapies Targeting Myocardial Fibrosis through the Inhibition of Transforming Growth Factor-Beta 1

Publisher： Karger

E-ISSN： 1421-9751|108|4|368-380

ISSN： 0008-6312

Source： Cardiology, Vol.108, Iss.4, 2007-02, pp. : 368-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Connective Tissue Growth Factor Does Not Affect Transforming Growth Factor-Beta 1-Induced Smad3 Phosphorylation and T Lymphocyte Proliferation Inhibition

By  

International Archives of Allergy and Immunology, Vol. 147, Iss. 2, 2008-06 ,pp. : 152-160

Karger

Access to resources Recommend Favorite

Transforming Growth Factor-Beta-1 Variants Are Not Associated with Chronic Nonalcoholic Pancreatitis

By  

Pancreatology, Vol. 5, Iss. 1, 2005-04 ,pp. : 75-80

Karger

Access to resources Recommend Favorite

Density-Dependent Shift of Transforming Growth Factor-Beta-1 from Inhibition to Stimulation of Vascular Smooth Muscle Cell Growth Is Based on Unconventional Regulation of Proliferation, Apoptosis and Contact Inhibition

By  

Journal of Vascular Research, Vol. 46, Iss. 2, 2008-07 ,pp. : 85-97

Karger

Access to resources Recommend Favorite

Expression Changes of Transforming Growth Factor-Beta1 and Thrombospondin-1 in Cavernous Tissues of Diabetic Rats

By  

Urologia Internationalis, Vol. 84, Iss. 2, 2010-03 ,pp. : 221-225

Karger

Access to resources Recommend Favorite

Transforming growth factor‐beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers

By  

DIABETIC MEDICINE, Vol. 19, Iss. 6, 2002-06 ,pp. : 440-447

John Wiley & Sons Inc

Access to resources Recommend Favorite